Insider · CIK 0001191249
Paul A Laviolette
Files at EW (Edwards Lifesciences Corp), PLSE (Pulse Biosciences, Inc.). First filing May 11, 2026, latest May 11, 2026.
In brief
Paul A Laviolette files SEC Form 4 as CEO and director at PLSE (Pulse Biosciences, Inc.), and also at EW (Edwards Lifesciences Corp). Since May 11, 2026, Paul A Laviolette has reported 2 open-market buys worth $591k and 0 open-market sells worth $0, the latest filed on May 11, 2026.
A track record needs three past buys with six months of prices behind them; Paul A Laviolette has 0, so none is measured yet.
The newest scored trade: bought $295k of PLSE on May 11, 2026, filed May 11, 2026, scored 59 (moderate). In the last 12 months: 2 buys worth $591k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PLSE: Pulse Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 59Moderate | Pulse Biosciences, Inc. | $295k 15,000 shares | - | +51% from low-25% from high | |
| 61Notable | Pulse Biosciences, Inc. | $295k 15,000 shares | +1773% | +51% from low-25% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | PLSE Pulse Biosciences, Inc. | POpen-market purchase Common Stock | +15,000 | $19.69 | $295k | 15,000 | May 11, 2026 |
| May 11, 2026 | PLSE Pulse Biosciences, Inc. | POpen-market purchase Common Stock | +15,000 | $19.69 | $295k | 15,846 | May 11, 2026 |
| May 8, 2026 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +3,251 | $0.00 | $0 | 17,552 | May 8, 2026 |
| May 9, 2025 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +3,528 | $0.00 | $0 | 14,301 | May 9, 2025 |
| Jan 9, 2025 | PLSE Pulse Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +450,000 | $0.00 | $0 | 450,000 | Jan 13, 2025 |
| Jan 9, 2025 | PLSE Pulse Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,050,000 | $0.00 | $0 | 1,050,000 | Jan 13, 2025 |
Questions about Paul A Laviolette
Answered from the filings on this page, as of the latest one.
Is Paul A Laviolette buying or selling?
In the last 12 months Paul A Laviolette reported 2 open-market buys worth $591k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $295k of PLSE on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Paul A Laviolette's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul A Laviolette has 0.
Where does Paul A Laviolette file Form 4?
Paul A Laviolette has filed Form 4 at PLSE (Pulse Biosciences, Inc.) as Chief Executive Officer; EW (Edwards Lifesciences Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.